Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104 ...

THE WOODLANDS, TX, March 21, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ ... s Board of Directors approved the grant of an inducement stock option on March 17, 2025 to purchase ...

The closing of the warrant inducement transaction is expected to ... laws of any such state or jurisdiction. About Tenon Medical, Inc. Tenon Medical, Inc., a medical device company formed in ...

The Inducement Grant was granted pursuant to Aligos ... its purpose-built pipeline of therapeutics with high unmet medical needs such as chronic hepatitis B virus infection, metabolic dysfunction ...

While the inducement award was granted outside of Disc's Amended and Restated 2021 Stock Option and Incentive Plan, the award is subject to terms and conditions substantially consistent with those set ...

LOS GATOS, CA / ACCESS Newswire / March 11, 2025 / Tenon Medical, Inc. (NASDAQ ... today announced its entry into a warrant inducement agreement with an existing healthcare-focused institutional ...

Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company focused on advancing innovative technologies to revolutionize ...